A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...

A Europe-based client approached DelveInsight to evaluate a long-term partnership for insights supporting their clinical, ...

A MUM and daughter have spoken about their dreams to visit Paris – after both were diagnosed with cancer. Cathy Barry and her ...

Researchers from Children's Hospital of Philadelphia (CHOP) have discovered the underlying biology that identifies a subset ...

A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show ...

Acute lymphoblastic leukaemia (ALL) is a type of blood cancer. Chemotherapy is the main treatment. We know that your child being diagnosed with cancer can be devastating. It's common to feel ...

A 28-year-old office executive battling a rare and aggressive form of blood cancer received a fresh lease of life after ...

Immunotherapies have shaped the cancer research space over the past decade, proving effective for the treatment of some ...

Findings of a recent study indicate that NUP98 rearrangements can significantly impact outcomes in patients with acute myeloid leukemia (AML).

The 66th American Society of Hematology Annual Meeting & Exposition will take place December 7-10, 2024, in San Diego, ...

We conducted a phase 1b–2 multicenter study of obe-cel in adults (≥18 years of age) with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). The main cohort, cohort 2A ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...